Inactive Instrument

Evogene Ltd Share Price Other OTC

Equities

IL0011050551

Biotechnology & Medical Research

End-of-day quote Other OTC
- USD - Intraday chart for Evogene Ltd
Sales 2024 * 14.99M 1.19B Sales 2025 * 25.85M 2.04B Capitalization 32.15M 2.54B
Net income 2024 * -22M -1.74B Net income 2025 * -19M -1.5B EV / Sales 2024 * 2.14 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.24 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.34%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 58 31/12/01
Director of Finance/CFO 57 31/03/22
Chief Tech/Sci/R&D Officer 48 31/12/04
Members of the board TitleAgeSince
Director/Board Member 79 16/11/21
Chairman 58 10/08/16
Director/Board Member 76 30/04/05
More insiders
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
More about the company